Latest Innovation News

Identitii Limited has refinanced a $0.8 million loan with an interest-free facility from its largest shareholder, Beauvais Capital, reducing interest expenses and freeing up company assets.

Prescient Therapeutics has secured FDA Fast Track designation for PTX-100 in treating relapsed Cutaneous T-Cell Lymphoma and dosed the first patient in its Phase 2a trial, supported by a recent $6.8 million capital raise.

Magnetite Mines has increased its Razorback iron ore resource estimate and extended key partnership negotiations, advancing its flagship project’s development. The company also reported promising metallurgical testwork and drew down funding to support ongoing feasibility studies.

Zeotech Limited’s latest quarterly report highlights a robust Preliminary Feasibility Study for its AusPozz™ low-carbon cement project, alongside successful commercial concrete trials and promising methane reduction technology.

Neurizon Therapeutics has made significant strides in developing its lead ALS drug candidate NUZ-001, unveiling a new liquid formulation and submitting a key regulatory response to the FDA. Clinical and preclinical data bolster hopes for broader neurodegenerative applications.

Micro-X has secured its first supply agreement with a leading US healthcare provider for its Rover Plus mobile radiology system, opening access to over 700 facilities nationwide.

Neurizon Therapeutics has secured a $1.5 million loan against its expected 2025 R&D tax rebate, boosting liquidity without diluting shareholders. This strategic move supports ongoing development of its neurodegenerative disease treatments.

Green360 Technologies has made significant strides in low-carbon cement development through a joint venture with PERMAcast and reported strong financial growth at its Pittong kaolin operations. The company is progressing towards commercial-scale production of sustainable building materials while expanding into new markets.

Thor Energy has reported significant progress in its natural hydrogen and helium exploration at the HY-Range Project, alongside strategic licence acquisitions and leadership changes. The company also signed a term sheet to sell a majority stake in its US uranium assets.

dorsaVi has acquired exclusive global rights to advanced RRAM technology, promising major performance gains in its biomedical sensors, while securing key contracts and raising $2.44 million to fuel US market growth.

Firebird Metals is developing Lithium Manganese Rich cathode materials to target next-generation solid-state batteries, aiming to strengthen its position in the evolving EV and high-energy battery markets.

DroneShield Limited has reported record revenue growth in 2Q25, driven by soaring demand for AI-powered counterdrone solutions amid a global surge in defense spending. The company’s expanding $2.33 billion sales pipeline and strong cash position position it well for future growth.